Viva Biotech in Shanghai enhances DMPK services for drug discovery; emphasizes critical PKPD in diverse modalities.
On December 29, 2025, in Shanghai, the significance of Drug Pharmacokinetics and Pharmacodynamics (PKPD) has grown with the expanding drug discovery field. Viva Biotech has addressed this by establishing an integrated platform to tackle the challenges.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments